naproxen
In       contrast, the incidence with naproxen was 36 (26%) of 137, significantly greater        than either placebo or celecoxib (P<.001).
In       contrast, the incidence with  @SUBJECT$  was 36 (26%) of 137, significantly greater         @PREDICAT$  either  @OBJECT$  or celecoxib (P<.001).